Only Half of Healthy Volunteers Experienced Psychotic Symptoms From THC, and Their Brains Responded Differently

When 21 healthy men received 10 mg oral THC, about half experienced transient psychotic symptoms while the other half did not, and fMRI revealed distinctly different brain activation patterns between the two groups.

Atakan, Z et al.·Psychological medicine·2013·Moderate EvidenceRandomized Controlled Trial
RTHC-00647Randomized Controlled TrialModerate Evidence2013RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Moderate Evidence
Sample
N=11

What This Study Found

In a double-blind, placebo-controlled study, 21 healthy men with minimal cannabis experience received 10 mg oral THC or placebo. About half (n=11) developed transient psychotic symptoms while the remainder (n=10) did not. The group experiencing psychotic symptoms made more inhibition errors and showed different brain activation in the left parahippocampal gyrus, bilateral middle temporal gyri, and right cerebellum.

Remarkably, THC had opposite effects on brain activation in the two groups in these regions. The psychosis-prone group also showed less activation in temporal and cerebellar regions independent of THC, suggesting pre-existing neural differences.

Key Numbers

21 healthy men. 10 mg oral THC. 11 developed transient psychosis, 10 did not. Differential activation in parahippocampal gyrus, middle temporal gyri, and cerebellum. THC had opposite directional effects on brain activation in the two groups.

How They Did This

Double-blind, placebo-controlled, pseudorandomized design. 21 healthy men with minimal cannabis experience received 10 mg oral THC or placebo. fMRI recorded during a go/no-go inhibition task. Participants split into transiently psychotic (n=11) and non-psychotic (n=10) groups based on PANSS positive scores after THC.

Why This Research Matters

This was the first demonstration that individual differences in sensitivity to THC's psychosis-inducing effects have a measurable neural basis. The finding that about half of participants experienced psychotic symptoms while the other half did not, with corresponding brain differences, helps explain why cannabis affects people so differently.

The Bigger Picture

This study provides biological evidence for what cannabis users have long known: the drug affects people very differently. The neural differences between susceptible and non-susceptible individuals may eventually help identify who is at risk for cannabis-related psychotic experiences.

What This Study Doesn't Tell Us

Small sample size (21 subjects). Only men were studied. The post-hoc split into groups based on symptom response means the groups were not randomly assigned. Minimal cannabis experience may not reflect how regular users respond. A single dose does not model chronic exposure.

Questions This Raises

  • ?Can the neural differences between susceptible and non-susceptible individuals be detected before cannabis exposure?
  • ?Would these findings replicate in women?
  • ?Do people who experience transient THC-induced psychosis have higher long-term psychosis risk?

Trust & Context

Key Stat:
THC had opposite effects on brain activation in susceptible vs. non-susceptible individuals
Evidence Grade:
Controlled experimental study with fMRI, but small sample and post-hoc grouping; moderate evidence.
Study Age:
Published in 2013. Research on individual vulnerability to THC-induced psychosis has continued with genetic and neuroimaging approaches.
Original Title:
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.
Published In:
Psychological medicine, 43(6), 1255-67 (2013)
Database ID:
RTHC-00647

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

Why does cannabis cause psychotic symptoms in some people but not others?

This study found that people who experienced THC-induced psychotic symptoms had different brain activation patterns in the temporal cortex and cerebellum, even before taking THC. This suggests pre-existing neural differences make some brains more susceptible to THC's psychosis-inducing effects.

Is experiencing psychosis from cannabis permanent?

In this study, the psychotic symptoms were transient, resolving after the drug wore off. However, experiencing transient psychotic symptoms from cannabis may indicate underlying vulnerability. Research suggests that repeated cannabis-induced psychotic experiences could increase the risk of developing a lasting psychotic disorder in susceptible individuals.

Read More on RethinkTHC

Cite This Study

RTHC-00647·https://rethinkthc.com/research/RTHC-00647

APA

Atakan, Z; Bhattacharyya, S; Allen, P; Martín-Santos, R; Crippa, J A; Borgwardt, S J; Fusar-Poli, P; Seal, M; Sallis, H; Stahl, D; Zuardi, A W; Rubia, K; McGuire, P. (2013). Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.. Psychological medicine, 43(6), 1255-67. https://doi.org/10.1017/S0033291712001924

MLA

Atakan, Z, et al. "Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.." Psychological medicine, 2013. https://doi.org/10.1017/S0033291712001924

RethinkTHC

RethinkTHC Research Database. "Cannabis affects people differently: inter-subject variation..." RTHC-00647. Retrieved from https://rethinkthc.com/research/atakan-2013-cannabis-affects-people-differently

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.